These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3934386

  • 1. New antihistaminic N-heterocyclic 4-piperidinamines. 2. Synthesis and antihistaminic activity of 1-[(4-fluorophenyl)methyl]-N-(4-piperidinyl)-1H-benzimidazol-2-a mines.
    Janssens F, Torremans J, Janssen M, Stokbroekx RA, Luyckx M, Janssen PA.
    J Med Chem; 1985 Dec; 28(12):1934-43. PubMed ID: 3934386
    [Abstract] [Full Text] [Related]

  • 2. New antihistaminic N-heterocyclic 4-piperidinamines. 1. Synthesis and antihistaminic activity of N-(4-piperidinyl)-1H-benzimidazol-2-amines.
    Janssens F, Torremans J, Janssen M, Stokbroekx RA, Luyckx M, Janssen PA.
    J Med Chem; 1985 Dec; 28(12):1925-33. PubMed ID: 4068010
    [Abstract] [Full Text] [Related]

  • 3. New antihistaminic N-heterocyclic 4-piperidinamines. 3. Synthesis and antihistaminic activity of N-(4-piperidinyl)-3H-imidazo[4,5-b]pyridin-2-amines.
    Janssens F, Torremans J, Janssen M, Stokbroekx RA, Luyckx M, Janssen PA.
    J Med Chem; 1985 Dec; 28(12):1943-7. PubMed ID: 3934387
    [Abstract] [Full Text] [Related]

  • 4. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B, Dordal A, Fort M, Galicia J, Farré AJ.
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(6):397-406. PubMed ID: 8892269
    [Abstract] [Full Text] [Related]

  • 5. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound.
    Van Wauwe J, Awouters F, Neimegeers CJ, Janssens F, Van Nueten JM, Janssen PA.
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):39-51. PubMed ID: 6114717
    [Abstract] [Full Text] [Related]

  • 6. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.
    Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A.
    Drugs R D; 2006 May; 7(4):219-31. PubMed ID: 16784247
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and structure-activity relationships of a new series of benzimidazoles as H1-antihistaminic agents.
    Cuberes MR, Contijoch M, Calvet C, Alegre J, Quintana JR, Frigola J.
    Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1287-92. PubMed ID: 9301027
    [Abstract] [Full Text] [Related]

  • 8. AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive rats.
    Nolan JC, Foxwell MH, Whitman LL, Yanni JM, Walsh DA, Kilpatrick BF, Johnson DN, Proakis AG.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1177-83. PubMed ID: 1972750
    [Abstract] [Full Text] [Related]

  • 9. The pharmacological profile of a specific, safe, effective and non-sedative anti-allergic, astemizole.
    Niemegeers CJ, Awouters F, Janssen PA.
    Agents Actions; 1986 Apr; 18(1-2):141-4. PubMed ID: 2873722
    [Abstract] [Full Text] [Related]

  • 10. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs.
    Kamei C, Mio M, Izushi K, Kitazumi K, Tsujimoto S, Fujisawa K, Adachi Y, Tasaka K.
    Arzneimittelforschung; 1991 Sep; 41(9):932-6. PubMed ID: 1724600
    [Abstract] [Full Text] [Related]

  • 11. 4-(Indolyl-3)-1-(benzimidazolonylalkyl)-piperidines, a novel group of potential antiallergy compounds.
    Freter K, Fuchs V, Barsumian E, Oliver JT.
    Arzneimittelforschung; 1985 Sep; 35(1A):272-6. PubMed ID: 2580540
    [Abstract] [Full Text] [Related]

  • 12. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
    Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A.
    Drugs R D; 2005 Sep; 6(6):371-84. PubMed ID: 16274260
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of passive cutaneous anaphylaxis by several histamine (H1) and serotonin antagonists in the rat.
    Metys J, Frycová H, Soucek R.
    Agents Actions; 1988 Apr; 23(3-4):331-3. PubMed ID: 3394585
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine.
    Barnett A, Iorio LC, Kreutner W, Tozzi S, Ahn HS, Gulbenkian A.
    Agents Actions; 1984 Jun; 14(5-6):590-7. PubMed ID: 6236679
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A, Bechtel WD, Kuhn FJ, Mierau J.
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [Abstract] [Full Text] [Related]

  • 16. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T, Saito T, Tajima S, Shimohara K, Ito K.
    Arzneimittelforschung; 1984 Oct; 34(7):805-10. PubMed ID: 6208915
    [Abstract] [Full Text] [Related]

  • 17. Effect of combined histamine H1 and H3 receptor blockade on cutaneous microvascular permeability elicited by compound 48/80.
    McLeod RL, Mingo GG, Kreutner W, Hey JA.
    Life Sci; 2005 Mar 04; 76(16):1787-94. PubMed ID: 15698856
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents.
    Iemura R, Kawashima T, Fukuda T, Ito K, Tsukamoto G.
    J Med Chem; 1986 Jul 04; 29(7):1178-83. PubMed ID: 2879912
    [Abstract] [Full Text] [Related]

  • 19. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K, Akagi M, Izushi K, Mio M.
    Methods Find Exp Clin Pharmacol; 1990 Oct 04; 12(8):531-9. PubMed ID: 1709434
    [Abstract] [Full Text] [Related]

  • 20. Syntheses of the metabolites of 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-1H benzimidazole difumarate (KG-2413) and related compounds.
    Iemura R, Hori M, Ohtaka H.
    Chem Pharm Bull (Tokyo); 1989 Apr 04; 37(4):962-6. PubMed ID: 2569942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.